A Multicentre, Randomized Phase III Study of Rituximab as Maintenance Treatment Versus Observation in Patients With Aggressive B-cell Lymphoma: NHL-13

Clinical trial NCT00400478 · COMPLETED

Trial details

NCT number: NCT00400478
Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diffuse Large B-Cell Lymphoma (DLBCL)Follicular NHL Grade 3b

Start date: 2006-01-01
Primary completion: 2013-03-01
Enrollment: 683

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.